NCT01574287View on ClinicalTrials.gov

Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Parathyroid Disease
Interventions
DRUG

FACBC

Drug is give intravenously over 2 minutes at time of scan

Trial Locations (1)

30032

Emory University, Atlanta

All Listed Sponsors
lead

David M. Schuster, MD

OTHER

NCT01574287 - Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas | Biotech Hunter | Biotech Hunter